Psychological and Psychiatric Factors As Predictors for Success in Sacral Neuromodulation Treatment
Authors
Affiliations
Unlabelled: What's known on the subject? and What does the study add? Sacral neuromodulation (SNM) is a well-established treatment for patients with chronic LUTS. The selection of eligible candidates could be improved by identifying factors that can predict a successful response. In the present study, we evaluated the role of various psychological and psychiatric factors in relation to SNM treatment.
Objective: • To evaluate if psychological and psychiatric factors can predict the outcome of test stimulation or permanent treatment with sacral neuromodulation (SNM).
Patients And Methods: • Between 2006 and 2009, patients with overactive bladder syndrome or non-obstructive urinary retention who were eligible for test stimulation were included. • All patients completed the Amsterdam Biographic Questionnaire (ABQ), which measures the personality traits of the patient, and the Symptom Check-List-90-Revised (SCL-90-R), which is a screening instrument for neuroticism, and for current level of complaints. • The results of the questionnaires were compared with the outcomes of test stimulation and permanent treatment. • In addition to the questionnaires, we also included the psychiatric history as a potential predictive factor.
Results: • On univariate analysis there was no relationship between the psychological characteristics and the outcome of test stimulation or the occurrence of adverse events (AEs) with permanent treatment. • A history of psychiatric disease was not related to the outcome of test stimulation, but was shown to be a positive predictor for the occurrence of AEs with permanent SNM treatment.
Conclusions: • In the present study there was no evidence that psychological screening with the ABQ or SCL-90-R can predict the outcome of SNM treatment. • Patients with a medical history of psychiatric disease appear to be more likely to encounter AEs with permanent SNM treatment.
Mancini V, Damaser M, Chermansky C, Ochoa C, Hashim H, Przydacz M Neurourol Urodyn. 2023; 43(6):1420-1430.
PMID: 38048061 PMC: 11610276. DOI: 10.1002/nau.25346.
van Doorn T, Reuvers S, Roobol M, Remmers S, Verbeek J, Scheepe J Ther Adv Urol. 2022; 14:17562872221090319.
PMID: 35464652 PMC: 9024161. DOI: 10.1177/17562872221090319.
Dudding T, Lehur P, Sorensen M, Engelberg S, Bertapelle M, Chartier-Kastler E Neuromodulation. 2021; 24(7):1247-1257.
PMID: 34264542 PMC: 9291141. DOI: 10.1111/ner.13494.
Predictive Factors in Sacral Neuromodulation: A Systematic Review.
Jairam R, Drossaerts J, Marcelissen T, Van Koeveringe G, Vrijens D, Van Kerrebroeck P Urol Int. 2021; 106(4):323-343.
PMID: 34058731 PMC: 9153358. DOI: 10.1159/000513937.
Feldkamp A, Amasyali A, Groegler J, Jellison F, Staack A Turk J Urol. 2020; 47(1):58-65.
PMID: 33112732 PMC: 7815242. DOI: 10.5152/tud.2020.20288.